Medpace Holdings (MEDP) Non-Current Deffered Revenue (2017 - 2018)
Medpace Holdings (MEDP) posted Non-Current Deffered Revenue of $4.0 million for Q3 2018, down 64.26% quarter-over-quarter from $11.1 million in Q2 2018, and down 81.14% year-on-year from $21.0 million in Q3 2017.
Medpace Holdings (MEDP) Non-Current Deffered Revenue (2017 - 2018) Analysis & Trends
Medpace Holdings (MEDP) has reported Non-Current Deffered Revenue for 2 consecutive years, with $4.0 million the latest figure, recorded in Q3 2018.
- Non-Current Deffered Revenue for Q3 2018 came in at $4.0 million, down 81.14% year-over-year; the trailing twelve-month figure through Sep 2018 was $4.0 million (down 81.14% YoY), and the FY2017 annual result was $11.5 million, changed N/A from the prior year.
- Non-Current Deffered Revenue was $4.0 million for Q3 2018 at Medpace Holdings, down from $11.1 million in the prior quarter.
- Over five years, Non-Current Deffered Revenue peaked at $21.4 million in Q2 2017 and troughed at $4.0 million in Q3 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | - |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | - |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 32.31 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 17.00 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | - |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | - |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | - |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | - |
| 10 | Medpace Holdings | 15.46 Bn | 14.81 Bn | 196.33 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 3.95 Mn |
| Jun 30, 2018 | 11.06 Mn |
| Mar 31, 2018 | 11.27 Mn |
| Dec 31, 2017 | 11.47 Mn |
| Sep 30, 2017 | 20.96 Mn |
| Jun 30, 2017 | 21.42 Mn |